Your browser is no longer supported. Please, upgrade your browser.
AGN Allergan plc daily Stock Chart
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-5.63 Insider Own0.10% Shs Outstand389.55M Perf Week4.54%
Market Cap91.84B Forward P/E13.63 EPS next Y17.29 Insider Trans- Shs Float389.55M Perf Month8.86%
Income-2446.20M PEG- EPS next Q3.38 Inst Own89.80% Short Float1.54% Perf Quarter-20.33%
Sales16.30B P/S5.63 EPS this Y23.00% Inst Trans-0.47% Short Ratio1.18 Perf Half Y-26.27%
Book/sh183.69 P/B1.28 EPS next Y21.77% ROA- Target Price292.63 Perf Year-23.74%
Cash/sh5.84 P/C40.39 EPS next 5Y11.85% ROE- 52W Range195.50 - 340.34 Perf YTD-24.56%
Dividend0.20 P/FCF- EPS past 5Y-50.40% ROI-1.30% 52W High-30.73% Beta0.65
Dividend %0.08% Quick Ratio0.90 Sales past 5Y33.40% Gross Margin71.80% 52W Low20.59% ATR6.35
Employees31200 Current Ratio1.00 Sales Q/Q48.10% Oper. Margin- RSI (14)54.53 Volatility2.27% 2.93%
OptionableYes Debt/Eq0.59 EPS Q/Q86.30% Profit Margin- Rel Volume1.54 Prev Close235.94
ShortableYes LT Debt/Eq0.53 EarningsMay 10 BMO Payout- Avg Volume5.08M Price235.75
Recom1.90 SMA205.98% SMA500.21% SMA200-15.64% Volume7,799,356 Change-0.08%
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-07-16Downgrade Susquehanna Positive → Neutral
Apr-06-16Downgrade Mizuho Buy → Neutral $330 → $250
Mar-31-16Reiterated Canaccord Genuity Buy $340 → $320
Feb-23-16Reiterated Mizuho Buy $354 → $330
Feb-23-16Reiterated Deutsche Bank Buy $308 → $339
Feb-19-16Initiated Wells Fargo Outperform
Nov-24-15Reiterated Mizuho Buy $340 → $354
Nov-13-15Reiterated Mizuho Buy $337 → $340
Oct-28-15Reiterated Leerink Partners Outperform $311 → $342
Oct-09-15Initiated Mizuho Buy
Sep-29-15Initiated Nomura Buy
Aug-07-15Reiterated RBC Capital Mkts Outperform $361 → $375
Aug-07-15Reiterated Deutsche Bank Buy $346 → $350
May-31-16 11:09PM  [$$] Icahn Takes Big Stake in Allergan, Endorses Drugmakers CEO at The Wall Street Journal
08:25PM  Carl Icahn Acquires a Large Position in Allergan (AGN) at Investopedia
07:38PM  [$$] Icahn Takes Big Stake in Allergan, Endorses Drugmaker's CEO at The Wall Street Journal
05:45PM  Business Highlights
05:30PM  [$$] ConAgra climbs on Jana nominees update at Financial Times
05:20PM  Top Trades: Biotech bottom in?
04:26PM  3 Reasons Not to Worry About High Corporate Debt Levels at
04:17PM  Tweets on the Street: Icahn Bets on Botox, SodaStream Makes Home-Brewing Easier
04:09PM  Markets Right Now: Stocks struggle to a mixed close
02:49PM  Stocks pare May gains as rate hike case builds
02:45PM  Pro: Allergan is becoming something
02:31PM  Carl Icahn Discloses Large Position In Allergan (AGN)
02:30PM  Trending Tickers: AGN, WR, CLF, CCE, MKTO
02:18PM  Carl Icahn says he bought a stake in Botox-maker Allergan
02:01PM  Here's Why Shares of Allergan Are Higher on Tuesday at TheStreet
01:37PM  Cramer: There Are Some Bargains Out There
01:31PM  Icahn is Not the Ackman of Allergan at Bloomberg
01:08PM  Tuesday links: a difficult place
12:40PM  [$$] Carl Icahn buys 'big' stake in Allergan at Financial Times
12:32PM  Carl Icahn Takes Large Position in Allergan
12:16PM  Maris: Icahn's stake shows AGN is on right path
12:10PM  Allergan and Medicines360 Announce Donation of Intrauterine Devices (IUD) to the CDC Foundation to Help Address Microcephaly Impact from Zika Virus in Puerto Rico PR Newswire
11:49AM  Icahn acquires "large" Allergan stake at USA TODAY
11:48AM  At Allergan, Carl Icahn Goes Back to Old Friend Saunders at The Wall Street Journal
11:41AM  [video]Icahn Bets on Allergan's Brett Saunders in Post-Pfizer Era
11:32AM  Carl Icahn acquires 'large position' in Allergan, backs CEO
11:30AM  Carl Icahn's Position Boosts Confidence in Allergan's CEO
11:15AM  Icahn, Chart, Valuation -- Allergan May Have It All
11:15AM  Carl Icahn May Be the Remedy for What's Ailing Allergan
11:10AM  Heres Why Traders Are Buzzing About These Five Stocks Today at Insider Monkey
11:07AM  What Did AGNs US Medical Aesthetics Segment Contribute in 1Q16?
11:02AM  Pfizer Inc. -- Moody's assigns A1 to Pfizer's new notes; negative outlook at Moody's
10:56AM  Carl Icahn takes large stake in Allergan at MarketWatch
10:53AM  Carl Icahn Recently Bought a Large Position in Allergan at Fortune
10:16AM  Carl Icahn's New Stake In Allergan
09:57AM  Allergan acknowledges Icahn investment
09:52AM  Done With Apple, Carl Icahn Makes A Bet On Tax-Inverter Allergan at Forbes
09:44AM  Icahn Takes Large Position in Allergan at Bloomberg
09:40AM  Allergan (AGN) Stock Up as Icahn Reveals Stake
09:37AM  Allergan's stock surges after Carl Icahn discloses 'large' stake at MarketWatch
09:20AM  Icahn reveals 'large' position in Allergan
09:19AM  Carl Icahn says he recently acquired a 'large position' in Allergan at CNBC
09:07AM  A Closer Look at Allergans US Brands Segment
07:31AM  Allergan Receives FDA Approval of TEFLARO® (ceftaroline fosamil) for Pediatric Patients PR Newswire
06:06AM  Buy These 5 Big Stocks for Big Gains in June
May-30-16 08:00PM  Allergan Can Climb Back to $268, Charts Say
02:49PM  Allergan, Bank of America and Monsanto: Doug Kass' Views
11:08AM  Understanding Allergans 1Q16 Revenue Stream
09:07AM  A Look at Allergans Growth Pharma Model
08:22AM  These 5 Big Pharma Stocks Are Ridiculously Cheap at Motley Fool
May-29-16 11:05PM  Pharma sector set for wave of mergers, acquisitions: study AFP
11:51AM  [$$] Teva investors fret over $41bn generic drugs deal at Financial Times
07:38AM  8 Top Stocks Billionaires Love at Motley Fool
May-28-16 03:46PM  The 5 Most Popular Stocks Among Hedge Funds Going Into Q2 at Insider Monkey
12:00PM  3 ETFs Affected by the Failed Pfizer-Allergan Merger (PFE, AGN) at Investopedia
May-27-16 04:16PM  Whats Allergans Growth Strategy?
04:16PM  How Do Allergans Valuations Compare to Its Peers?
02:56PM  How You Can Lose Money Lets Count The Ways!
11:53AM  Allergan: Standing Out From the Pack at
09:43AM  2016 Global 2000: The World's Largest Drug And Biotech Companies at Forbes
05:43AM  2016 Global 2000: The World's Largest Drug And Biotech Companies
May-26-16 10:55AM  These 5 Large-Cap Stocks Are Entering Breakout Mode
06:38AM  5 Health Care Stocks Whose Charts Tell You to Wait to Buy
May-25-16 06:19PM  Buy Pfizer, Chevron, Newell Brands and Enjoy the Profits
05:37PM  Why Pfizer, Chevron and Newell Brands Could be Great For Your Portfolio at TheStreet
08:39AM  Billionaires are Dumping These 3 Stocks at Motley Fool
May-24-16 05:41PM  Billionaires Are Bailing on Pfizer, Inc -- Should You? at Motley Fool
11:53AM  Allergan, Inc. (AGN) Receives Good News from Japan at Insider Monkey
11:10AM  4 Stocks That Hedge Fund Managers Love and Own the Most Of
10:54AM  What the Sharp Dropoff in Buybacks Says About the Market
09:26AM  Is This the Perfect Time to Buy Teva?
08:26AM  Allergan Says FDA Accepts Its NDA Filing Of Oxymetazoline HCI Cream 1.0%
08:25AM  Billionaires Lightened Their Load on These 3 Widely-Held Stocks in Q1 at Motley Fool
07:31AM  Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0% PR Newswire
06:53AM  5 Health Care Stocks John Paulson Is Betting On in 2016
May-23-16 05:58PM  Final Trades: Salesforce, Allergan, & more
04:49PM  Allergan to Do Smaller Deals and Boost Credit Rating
04:30PM  Allergan's BOTOX Vista® (botulinum toxin type A) Receives National Marketing Authorisation in Japan for Treatment of Crow's Feet Lines in Adult Patients PR Newswire
02:28PM  Anti-Growth Policies Hurt Investors at Forbes
12:22PM  Allergan CEO says company is "weeks away" from closing Teva deal Reuters
06:02AM  CF Industries Pulls $8 Billion Takeover of OCI Assets
12:31AM  Criminal Trials of Former Health-Care Executives Set to Begin at The Wall Street Journal
May-22-16 07:00AM  Allergan Launches 'IBS-D on Tract,' New Online Resource to Support Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) PR Newswire
05:30AM  Criminal Trials of Former Health-Care Executives Set to Begin at The Wall Street Journal
May-21-16 09:00AM  Our Full Interview With Michael Van Biema
May-20-16 11:27AM  Specialty Pharma Stocks are CheapBut Only Some are Worth Buying at
May-19-16 06:53PM  ETFs with exposure to Allergan Plc : May 19, 2016
01:46PM  Billionaire David Shaws Fund Boosts Exposure to Yahoo, Allergan & Others at Insider Monkey
09:45AM  What You Need To Know About Baupost Groups Top Stock Picks: from Allergan to EMC at Insider Monkey
07:30AM  Allergan to Present at the Bernstein 32nd Annual Strategic Decisions Conference PR Newswire
May-18-16 05:01PM  Michael Van Biema On Why Valeant Pharmaceuticals Failed
01:17PM  Billionaire Dan Loeb Reveals His Top Stock Picks; Allergan plc (AGN) Disappoints at Insider Monkey
10:07AM  Why Is Anacor Trading through the Deal Terms?
09:30AM  Facebook, Adobe, Among Maverick Capitals Major Q1 Buys as It Looks to Dominate Its Peers Yet Again at Insider Monkey
09:07AM  Jim Cramer doesnt beat the market at MarketWatch
09:07AM  Jim Cramer doesnt beat the market at MarketWatch
08:51AM  Pfizer Zeroes in on Anacor
08:51AM  Pfizer Zeroes in on Anacor Company Spotlight
May-17-16 04:15PM  Allergan to Present at the UBS 2016 Global Healthcare Conference PR Newswire
01:04PM  ALLERGAN PLC Financials
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, and medical aesthetics, as well as dermatology and plastic surgery. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. Allergan plc also distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Parsippany, New Jersey.